Home Product Afatinib


Afatinib(Gilotrif™) is a targeted therapy used to treat metastatic non-small cell lung cancer (NSCLC) that has certain EGFR mutations as detected by an FDA-approved test.

Afatinib is classified as kinase inhibitors, Binds certain protein (EGFR) in some tumors, and used in treating a certain type of lung cancer (non-small cell lung cancer). Binds certain protein (EGFR) in some tumors.

Possible Side Effects of Afatinib

  • Mouth sores.
  • Pain/redness/swelling of lips.
  • Dry/itchy skin.
  • Acne.
  • Nose bleed.
  • Runny nose.
  • Nausea/vomiting.
  • Loss of appetite.

If any of these effects persist or worsen, consult your doctor immediately.

Diarrhea is a common side effect.


There are no reviews yet.

Be the first to review “Afatinib”

Your email address will not be published. Required fields are marked *